Emergent BioSolutions (EBS) Tops Q1 EPS by 6c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $7.02 +4.00%
Revenue Growth %: -45.6%
Financial Fact:
Other income (expense), net: -234K
Today's EPS Names:
ALZN, ASPU, USAU, More
Revenue Growth %: -45.6%
Financial Fact:
Other income (expense), net: -234K
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q1 EPS of $0.18, $0.06 better than the analyst estimate of $0.12. Revenue for the quarter came in at $307.5 million versus the consensus estimate of $283.57 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s said to plan value strategy overhaul to revive US sales growth
- UBS sees a negative catalyst ahead for Nike: Here’s what to watch
- Could Affirm be a $200 stock?
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
